Stanford University
Showing 51-100 of 1,989 Results
-
A Dale Kaiser
Member, Bio-X
Current Research and Scholarly InterestsHow are genes regulated to construct a developmental program? How do signals received from other cells change the program and coordinate it for multicellular development? The approach taken by our laboratory group to answer these questions utilizes biochemistry and genetics; genetics to isolate mutants that have particular defects in development and biochemistry to determine the molecular basis of the defects. We study swarming in Myxococcus xanthus that builds fruiting bodies.
-
Alexander D. Kaiser
Instructor, Cardiothoracic Surgery
BioAlexander Kaiser, PhD, is an applied mathematician and computational scientist who researches modeling and simulation of heart valves, focused on congenital heart valve disease and its surgical treatment. His recent research explores simulation-guided design of aortic valve repair of complex congenital heart defects. He has developed novel, nearly first-principles modeling methods for heart valves called elasticity-based design. These methods produce robust and realistic flows in fluid-structure interaction simulations. Dr. Kaiser is an Instructor in Cardiothoracic Surgery at Stanford University working with Michael Ma and Alison Marsden. He completed his PhD in Mathematics with Charles Peskin at the Courant Institute of Mathematical Sciences at New York University, where he was awarded the Kurt O. Friedrichs Prize for Outstanding Dissertation in Mathematics.
-
Pooja Kakar
Member, Maternal & Child Health Research Institute (MCHRI)
Current Research and Scholarly InterestsAs a breastfeeding medicine physician, I am passionate about advocating for mother-infant dyads and supporting their breastfeeding journeys. Additionally, I am interested studying and addressing disparities in initiation and duration of breastfeeding, particularly in lower-resourced populations, by building and advancing community partnerships.
I am also interested in the use of digital health tools to advance upstream determinants of health in community-based settings. My current funded research projects include: 1) Providing a telehealth-based, weight control program to children with obesity from lower-income, racial and ethnic minority families (Gardner GOALS) and 2) Assessing and addressing disparities in healthy behaviors in families from under-resourced settings through the use of a secure, multilingual mobile neighborhood app (Our Voice: Beyond Clinic Walls). -
Anusha Murali Kakolu, PhD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioAnusha Murali Kakolu, PhD (she/her) received her PhD in clinical psychology from Palo Alto University and completed her predoctoral pediatric psychology residency at the Cleveland Clinic, followed by a postdoctoral residency at Kaiser Permanente Santa Clara Medical Center. She also holds a master’s degree in mental health counseling and behavioral medicine from Boston University School of Medicine.
Anusha’s research and clinical work focus particularly on pediatric health psychology and anxiety. She has a strong commitment to supporting diverse youth and their families, especially those with complex medical conditions. Her training spans multiple specialties, including solid organ transplant, nephrology, endocrinology, genetic conditions, hematology, and oncology.
Anusha is also a passionate educator, serving as adjunct faculty in the doctoral and master’s programs at various universities. She is deeply dedicated to teaching, mentorship, and the supervision of students and trainees and is actively involved in several mentorship programs with the APA. She is an avid baker and yogi and enjoys reading and traveling -
Sharada Kalanidhi
Director of Data Science, Biochemistry - Genome Center
Current Role at StanfordParaphrasing the mathematician Alexander Grothendieck: the essential thing is to pose problems in the right framework.
Sharada is developing a new field, Mathematical Medicine, which applies pure mathematical frameworks to genomic and multi-omic data for quantitative, personalized diagnosis. This approach explores alternatives to prevailing cohort-based statistical paradigms, particularly in complex clinical cases that have resisted standard methods.
After more than a decade of research and close collaboration with biochemists at the Stanford Genome Technology Center (Dept. of Biochemistry), Sharada concluded that the mathematics currently used for multi-omic diagnosis is inadequate for the level of biological and clinical complexity being attempted. Her conclusion echoes the perspective of the mathematician Mikhail Gromov: “This area does not yet exist. It will have to be invented.” Mathematical Medicine represents one possible construction of such an area.
This field is focused on the development of an intermediate translation layer between cohort-based statistical models and individualized multi-omic diagnosis and clinical decision-making. Without this mathematical layer, the clinical adoption of multi-omic data- particularly for complex cases- has been limited. As a result, many complex, multi-system conditions remain undiagnosed or misdiagnosed for long periods, delaying effective treatment and, in some cases, allowing disease processes to worsen. Additionally, what is learned from rare and extreme cases proves highly informative for the rest of the population.
Further information on this field, including opportunities for early philanthropic partnerships, is available at: https://mathmed-2026.web.app/ -
Anusha Kalbasi, MD
Associate Professor of Radiation Oncology (Radiation Therapy)
BioDr. Kalbasi is a physician-scientist at the Stanford Cancer Institute. In the clinic, Dr. Kalbasi is a radiation oncologist specializing in the treatment of patients with sarcoma and other solid tumors, with expertise in early phase clinical trials related to immunotherapy, cellular therapy, and radiation therapy.
The Kalbasi laboratory studies cancer immunology, with a focus on understanding—and re-engineering—the molecular conversations that immune cells have with one another and with cancer cells, especially through cytokines. By mapping how these signals are sent, received, and interpreted within immune cells and cancer cells, the lab aims to design next-generation immunotherapies that deliver the right messages at the right time—making cancer-fighting cells more potent, more persistent, and more precise. -
Alexandr Kalinin
Affiliate, Chan Zuckerberg Biohub
BioAlexandr Kalinin is a Senior Machine Learning Scientist in the Computational Imaging group at the Biohub. At the intersection of AI and bioimaging, his research focuses on developing foundational models for virtual staining and dynamic profiling of cells across biological scales and states. He holds a PhD in Bioinformatics from the University of Michigan (2018) and a Master’s degree in Applied Mathematics from Novosibirsk State Technical University, Russia. Before joining Biohub, Alexandr was a Computational Scientist II at the Imaging Platform, Broad Institute of MIT and Harvard. He also previously was a Fulbright Visiting Graduate Researcher at UCLA and an International Postdoctoral Fellow at Shenzhen Research Institute for Big Data, China.
-
Kirill Olegovich Kalinin
Staff, Finance
Casual - Non-Exempt, Hoover InstitutionBioI am a political methodologist and comparativist with expertise in statistical analysis, machine learning, artificial intelligence, election forensics, survey methodology, and statistical software development. Since 2017, I have worked at Stanford University's Hoover Institution in various positions, including National Fellow, Researcher, and Data Analyst. Prior to joining Stanford, I studied and worked at the University of Michigan, where I earned my PhD in political science in 2017. For more information, please visit my website at www.kirillkalinin.com.
-
Agnieszka Kalinowski
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioI am a translational physician-scientist committed to understanding the pathophysiology of schizophrenia to identify disease-modifying therapeutic interventions. I examined the role of C4 protein activation in clinical samples from individuals with schizophrenia compared to controls, its relationship to C4 CNV and effect on blood brain barrier permeability using in vitro model systems. I contributed to identifying LINE-1 insertions in postmortem brain samples of individuals with schizophrenia and C4 copy number variation (CNV) in pediatric patients with neuropsychiatric symptoms. Since accumulating evidence points to the synapses as the locus of pathology in schizophrenia, I am focusing my current research effort to defining the underlying abnormality in synapses in schizophrenia using a combination of in vitro iPS based model systems and postmortem brain samples, and applying cutting-edge techniques like spatial transcriptomics and array tomography.
-
Nathan Kalinowski, D.M.D.
Clinical Assistant Professor, Surgery - Plastic & Reconstructive Surgery
BioDr. Nathan Kalinowski is a Hospital Dentist and Clinical Assistant Professor in Dental Medicine and Surgery. He performs medically necessary dental clearance and extractions for patients preparing for cardiac surgery, radiation therapy, or organ transplantation. He also performs surgical treatment of infection and trauma to the teeth and supporting alveolar bone including reconstruction using dental implants.
-
Mausam Kalita
Physical Science Research Professional 2, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordSenior Research Scientist: a) cold chemical synthesis— Synthesis of the 12C and 19F- HPLC standards and precursors for 11C- and 18F- labeling
b) Radiosynthesis— Introduction of 11C or 18F radioisotopes into small molecules to develop novel PET tracers, that can track activated myeloid cells in neurodegenerative disease, c) radiometal labeling— 64Cu and 89Zr labeling of monoclonal antibodies that target immune receptors, d) clinical translation— To follow FDA guidelines for translating preclinically validated tracers into humans in the cyclotron and radiochemistry facility (CRF) of the Stanford University -
Renata Kallosh
Stanford W. Ascherman, MD Professor, Emerita
BioWhat is the mathematical structure of supergravity/string theory and its relation to cosmology?
Professor Kallosh works on the general structure of supergravity and string theory and their applications to cosmology. Her main interests are related to the models early universe inflation and dark energy in string theory. She develops string theory models explaining the origin of the universe and its current acceleration. With her collaborators, she has recently constructed de Sitter supergravity, which is most suitable for studies of inflation and dark energy and spontaneously broken supersymmetry.
She is analyzing possible consequences of the expected new data from current and future cosmological observations, including LiteBIRD satellite CMB data. These results may affect the relationship between superstring theory and supergravity, and the real world. Professor Kallosh works, in particular, on future tests of string theory by CMB data and effective supergravity models with flexible amplitude of gravitational waves produced during inflation. -
Arpita Kalra
Marketing and Engagement Director, Precourt Institute for Energy
BioArpita Kalra is the Director for Marketing and Engagement at Precourt Institute for Energy. In this role she oversees the engagement and outreach efforts for the Stanford Energy brand. Prior to Stanford, she worked in the advertising industry where she developed and executed marketing campaigns across print, electronic and social media. Arpita holds a masters in Marketing Communications from the Mudra Institute of Communications, Ahmedabad (MICA) in India and a bachelors in Statistics from Delhi University.
-
Praveen Kalra
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Praveen Kalra is Board Certified in Anesthesia and in Critical Care. He specializes in trauma, orthopedic, brain and spine surgery, urology, and cancer surgery. He was appointed Fellow of the American Society of Anesthesiology (FASA) in 2023. Appointed Medical Director of Sustainability for Stanford Healthcare in Dec 2023.
His professional interests include devising protocols for patient safety, informed consent, reducing the impact of anesthetics on the environment, addressing climate change by reducing green house gas emissions in the health care setting, resident education to emphasize evidence based safe care and mentoring medical students. He has been in practice for over 18 years.
Received the Inaugural Sustainability Ambassador Award in 2022 at SHC for removing Desflurane (anesthetic gas with highest global warming potential) from the OR and undertaking multiple initiatives such as creating a Green Team at SHC, an elective Green Rotation for residents, green curriculum video series and addressing plastic & biohazardous waste in the OR. Current projects are focused on decommissioning nitrous oxide pipelines in the OR. As Medical Director of Sustainability, I work on collaborating with experts, fostering clinician engagement in change management, and spearheading transformative initiatives.
Dr. Kalra completed his residency in Anesthesia from Harvard Medical School’s Beth Israel Deaconess Hospital and a fellowship in Critical Care from Johns Hopkins Hospital, Baltimore. -
Julia Kaltschmidt
Professor of Neurosurgery
Current Research and Scholarly InterestsThe lab’s primary research interest is to understand how specific neuronal circuits are established. We use mouse genetics, combinatorial immunochemical labeling and high-resolution laser scanning microscopy to identify, manipulate, and quantitatively analyze synaptic contacts within the complex neuronal milieu of the spinal cord and the enteric nervous system.
-
Neil M. Kalwani, MD, MPP
Clinical Instructor, Medicine - Cardiovascular Medicine
BioDr. Neil M. Kalwani is a board-certified, fellowship-trained cardiologist with Stanford Health Care. He is also a clinical instructor in the Department of Medicine, Division of Cardiovascular Medicine at Stanford University School of Medicine. In addition, he serves as director of preventive cardiology at the Veterans Affairs (VA) Palo Alto Health Care System.
Dr. Kalwani specializes in general and preventive cardiology care. He has expertise in treating high cholesterol and other risk factors to prevent and stop the progression of coronary artery disease and other forms of atherosclerosis. He provides compassionate care centered around his patients' goals and prioritizes effective therapies based on the latest evidence to improve heart health and overall well-being.
Dr. Kalwani’s research focuses on innovations in care delivery designed to improve the value of care for people living with cardiovascular disease. He is especially interested in telemedicine and its impact on cardiology care, including on quality of care, practice patterns, and access. He has also investigated clinical decision support for cardiac testing, measurement of patient-reported outcomes for heart disease, and lipoprotein (a) testing patterns.
Dr. Kalwani has published his research in many peer-reviewed journals, including Circulation, the American Heart Journal, the American Journal of Preventive Cardiology, and the Journal of Telemedicine and Telecare. He has also presented his research at the American College of Cardiology (ACC) and American Heart Association (AHA) Scientific Sessions. His presentations have covered topics ranging from telemedicine’s effect on care delivery to the impact of physician productivity assessment on medical center performance.
Dr. Kalwani is a member of the ACC, AHA, and American Society of Echocardiography (ASE).
